Skip to main content
Equibles

Carol D. Gallagher, Pharm D.

Chairman

Atara Biotherapeutics, Inc. (ATRA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Carol D. Gallagher, Pharm D.

Carol D. Gallagher, Pharm D. is recorded as Chairman at Atara Biotherapeutics, Inc. (ATRA). Atara Biotherapeutics, Inc. reported in an 8-K filed December 19, 2022 that Carol D. Gallagher, Pharm D. was appointed Chair of the Board, effective December 19, 2022.

“effective as of December 19, 2022, the Board appointed Carol D. Gallagher, Pharm D., an independent member of the Board, to succeed Mr. Renaud as Chair of the Board and, in accordance with Section 16 of the Company's Second Amended and Restated Bylaws, reduced the number of directors on the Board from ten to eight directors.”
Atara Biotherapeutics, Inc. Form 8-K, filed December 19, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Atara Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.